概括
在息治疗中使用阿片类药物控制症状并不会缩短寿命. 患者在生命结束时接受增加的阿片类药物剂量并没有经历更短的存活期,反驳了人们对加速死亡的担忧.
科学领域:
- 抚慰性护理医学 抚慰性护理医学
- 疼痛管理 疼痛管理
- 在生命末期的护理.
背景情况:
- 公众和专业人士对阿片类药物使用在症状管理期间可能缩短生命存在担忧.
- 双重效应理论经常被用来证明阿片类药物用于症状控制的合理性.
研究的目的:
- 为了调查生命最后一周的阿片类药物使用模式.
- 为了确定阿片类药物管理或剂量是否会增加息治疗患者的冲击生存时间.
主要方法:
- 对阿片类药物使用模式的回顾性分析.
- 包括238名连续入住息治疗病房的患者.
- 检查过去24小时内阿片类药物的剂量,以及生命结束时的剂量调整.
主要成果:
- 在生命的最后24小时内,阿片类药物的中位数剂量很低 (26.4毫克).
- 患者在生命末期接受增加的阿片类药物剂量并没有表现出更短的生存期.
- 在接受阿片类药物增加的组和没有接受阿片类药物增加的组之间没有观察到统计学上显著的生存差异.
结论:
- 在息治疗中使用阿片类药物控制症状与生存时间缩短无关.
- 双重效应理论可能不需要证明阿片类药物用于终身症状管理的必要性.
- 研究结果支持使用阿片类药物的安全和道德,以减轻绝症患者的痛苦.
相关概念视频
Ethical Dilemmas II
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
Time Course of Drug Effect
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
IV Infusion to Oral Dosing: Conversion Methods
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Ending Relationships
The dissolution of intimate relationships presents complex emotional and psychological challenges, particularly when emotional bonds are strong, the relationship is long-standing, and perceived alternatives are limited. This distress often intensifies in romantic breakups, where the initiator may experience greater turmoil than the rejected partner. Contributing factors include residual attachment, guilt over causing pain, and uncertainty about how to manage the situation. The stress is further...


